30 Day Trial

Nexxt Spine Introduces Stand Alone Cervical Interbody

Nexxt Spine received FDA 510(k) clearance for the NEXXT MATRIXX® Stand Alone Cervical interbody fusion device.

Smith & Nephew Up +1.6% in 2Q19 on Sports Medicine

Smith & Nephew reports 2Q19 orthopedic revenue of USD $892MM, +1.6% vs. 2Q18.

ConMed Orthopedic Revenue +Up 5.1% in 2Q19

ConMed reports 2Q19 orthopedic revenue of USD $115.8MM, +5.1% vs. 2Q18.

Bio2 Technologies Enrolls First Vitrium Patient in Cervical Spine Fusion Trial

Bio2 Technologies enrolled the first patient in the Investigational Device Exemption trial of the Vitrium cervical interbody device.

Alphatec Closes Public Stock Offering

Alphatec closed its underwritten public offering of ~12.5MM shares of common stock for $4.60/share, receiving gross proceeds of ~US $57.6MM.

LimaCorporate Enters Distribution Agreement with G21

LimaCorporate completed an agreement to distribute G21's SpaceFlex Cement Spacer portfolio in the European Economic Area, Switzerland, Australia and New Zealand markets.

Centric Medical Launches TARSA-LINK Stand-Alone Wedge Fixation Study

Centric Medical initiated a clinical study of the TARSA-LINK™ Stand-Alone Wedge Fixation System.

Globus Medical Acquires StelKast, Hip and Knee Device Company

Globus Medical (GMED) acquired StelKast, manufacturer of implants and instruments for hip and knee replacement, for USD $24.1MM in cash plus potentially $4.3MM in product sales milestones. GMED plans to release a robotic system for joint reconstruction in late 2020.

Medicrea Gains FDA Clearance of TULIP GENESIS Top loading Screw

Medicrea received FDA clearance to market the TULIP GENESIS™ top loading screw, the final element in its UNiD™ ASI spine surgical planning platform.

NuVasive Up 3.7% on US Spinal Hardware in 2Q19

NuVasive posts 2Q19 revenue of USD $292.1MM, +3.7% vs. 2Q18.

 



It's important to know that ORTHOFLASH (like many ORTHOWORLD resources) is included with Membership. The full menu of Membership benefits is outlined on this pageStill have questions? Or, would you prefer personal attention?
Fran Bursic welcomes your inquiry by phone at 440.543.2101 or via 
email.

Read more from ORTHOWORLD: